| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||||||
| Brief Title † | Magnetic Resonance Imaging at Different Levels of Magnetic Intensity | ||||||||
| Official Title † | Magnetic Resonance at 1.5 and 3 Tesla | ||||||||
| Brief Summary | Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI uses different levels of magnetic fields to create images of the body and organs. Occasionally, researchers will give patients undergoing a MRI an injection of a substance called gadolinium. Gadolinium works by brightening areas of the magnetic resonance image, thereby improving the contrast. In this study researchers will use magnetic resonance imaging and contrast substances, like gadolinium, on normal volunteers in order to evaluate different aspects of its performance. Information gathered from this study may be used to develop more specific research studies involving MRI. |
||||||||
| Detailed Description | Technical evaluation of magnetic resonance imaging and spectroscopy will be performed on normal volunteers. These studies will be conducted in the MRI systems located at the NIH. These studies may involve the intravenous administration of commercially available MR contrast media and exercise. The results will be used to evaluate the performance of various pulse sequences, gradient coils, and RF coils on human subjects and will provide essential ground work for specific patient protocols. |
||||||||
| Study Phase | |||||||||
| Study Type † | Observational | ||||||||
| Study Design † | |||||||||
| Primary Outcome Measure † | |||||||||
| Secondary Outcome Measure † | |||||||||
| Condition † | Cardiovascular Disease Healthy |
||||||||
| Intervention † | |||||||||
| MEDLINE PMIDs | 7862963, 1889423, 7928216 | ||||||||
| Links | NIH Clinical Center Detailed Web Page  |
||||||||
| Recruitment Information Fields | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Enrollment † | 600 | ||||||||
| Start Date † | November 1996 | ||||||||
| Completion Date | |||||||||
| Eligibility Criteria † |
Any normal volunteer above the age of 18 who is capable of giving informed consent. EXCLUSION CRITERIA: A subject will be excluded if he/she has a contraindication to MR scanning such as:
EXCLUSION CRITERIA FOR GADOLINIUM ENHANCED STUDIES:
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years to 80 Years | ||||||||
| Accepts Healthy Volunteers | Yes | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | United States | ||||||||
| Administrative Information Fields | |||||||||
| NCT ID † | NCT00001619 | ||||||||
| Organization ID | 970026 | ||||||||
| Secondary IDs †† | 97-H-0026 | ||||||||
| Study Sponsor † | National Heart, Lung, and Blood Institute (NHLBI) | ||||||||
| Collaborators †† | |||||||||
| Investigators † | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | August 2008 | ||||||||
| First Received Date † | November 3, 1999 | ||||||||
| Last Updated Date | October 21, 2008 | ||||||||
|
